ACD-A is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Fenwal, Inc.. The primary component is Dextrose Monohydrate; Sodium Citrate; Anhydrous Citric Acid.
| Product ID | 0942-0641_0117e68c-08df-40f0-9e1f-aeb50ce17a6e |
| NDC | 0942-0641 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ACD-A |
| Generic Name | Anticoagulant Citrate Dextrose Solution Formula A |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2007-03-01 |
| Marketing Category | NDA / NDA |
| Application Number | BN160918 |
| Labeler Name | Fenwal, Inc. |
| Substance Name | DEXTROSE MONOHYDRATE; SODIUM CITRATE; ANHYDROUS CITRIC ACID |
| Active Ingredient Strength | 12 g/500mL; g/500mL; g/500mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2007-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | BN160918 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2007-03-01 |
| Marketing Category | NDA |
| Application Number | BN160918 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2007-03-01 |
| Ingredient | Strength |
|---|---|
| DEXTROSE MONOHYDRATE | 12.25 g/500mL |
| SPL SET ID: | 22805f0d-ba58-41ea-b245-19980abcda22 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0942-0641 | ACD-A | Anticoagulant Citrate Dextrose Solution Formula A |
| 0942-9005 | ACD-A | Antiocoagulant Citrate Dextrose Solution, Formula A |
| 53157-796 | ACD-A | Anticoagulant Citrate Dextrose Solution A |